Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -6.061% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] NS(=O)(=O)c1ccc(NC(=S)NNC(=O)c2cccs2)cc1
[b] O=C(NCc1cccs1)c1cc(-c2ccccc2)on1
[c] Cc1cc(/C=C(\C#N)C(=O)NC2CC2)c(C)[nH]1
[d] CC1CN(S(=O)(=O)c2cccc(C(=O)N=c3sccn3C)c2)CC(C)O1
[e] Cc1ccc(/C=N/NC(=O)c2cc(-c3cccnc3)nc3ccccc23)cc1
Answer: d. CC1CN(S(=O)(=O)c2cccc(C(=O)N=c3sccn3C)c2)CC(C)O1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CN(S(=O)(=O)c2cccc(C(=O)N=c3sccn3C)c2)CC(C)O1
CC1CN(S(=O)(=O)c2cccc(C(=O)N=c3sccn3C)c2)CC(C)O1
3-(2,6-dimethylmorpholin-4-yl)sulfonyl-N-(3-methyl-1,3-thiazol-2-ylidene)benzamide